These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3501190)

  • 1. T cell subsets controlling graft-v-host disease in mice.
    Sprent J; Korngold R
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):41-7. PubMed ID: 3501190
    [No Abstract]   [Full Text] [Related]  

  • 2. Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.
    Carmody L; Atkinson K; Cooley M; Chapman G; Biggs J; McKenzie I
    Transplant Proc; 1987 Apr; 19(2):2876-8. PubMed ID: 3105125
    [No Abstract]   [Full Text] [Related]  

  • 3. Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions.
    Truitt RL; Ash RC
    Prog Clin Biol Res; 1987; 244():409-21. PubMed ID: 3310003
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum.
    Oluwole SF; Engelstad K; Hardy MA
    Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974
    [No Abstract]   [Full Text] [Related]  

  • 5. Effector cells of lethal graft-versus-host disease (GVHD) in nude mice.
    Uenaka A; Mieno M; Kuribayashi K; Shiku H; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3031-2. PubMed ID: 2784924
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and specificity of T cell subsets in the mouse.
    Sprent J; Webb SR
    Adv Immunol; 1987; 41():39-133. PubMed ID: 2961215
    [No Abstract]   [Full Text] [Related]  

  • 8. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 9. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allorecognition and graft-versus-host disease.
    Theobald M
    Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 12. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell subsets and graft-versus-host disease.
    Korngold R; Sprent J
    Transplantation; 1987 Sep; 44(3):335-9. PubMed ID: 2957834
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.
    Holländer GA; Widmer B; Burakoff SJ
    J Immunol; 1994 Feb; 152(4):1609-17. PubMed ID: 7907102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow as a priming site for T-cell responses to blood-borne antigen.
    Feuerer M; Beckhove P; Garbi N; Mahnke Y; Limmer A; Hommel M; Hämmerling GJ; Kyewski B; Hamann A; Umansky V; Schirrmacher V
    Nat Med; 2003 Sep; 9(9):1151-7. PubMed ID: 12910264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effects of mouse ICOS-Ig gene-modified mouse dendritic cells on T cells.
    Wang G; Zhu L; Hu P; Zhu H; Lei P; Liao W; Yu B; Gong F; Shen G
    Cell Mol Immunol; 2004 Apr; 1(2):153-7. PubMed ID: 16212904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.